| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 13p12 |
RNR1 |
Ribosomal RNA-1 |
180450 |
|
|
A |
|
| 13p11 |
IL17D |
Interleukin 17D |
607587 |
|
?associated with Hodgkin lymphoma |
REc |
|
| 13q |
CLQTL1, CLF |
Cholesterol level quantitative trait locus 1 |
604595 |
[Cholesterol level QTL 1] (2) |
|
Fd |
|
| 13q |
RPL21 |
Ribosomal protein L21 |
603636 |
|
|
REa, R |
|
| 13q11 |
GJA3, CX46, CZP3, CAE3 |
Gap junction protein, alpha-3, 46kD (connexin 46) |
121015 |
Cataract, zonular pulverulent-3, 601885 (3) |
|
REa, A, Fd |
14(Gja3) |
| 13q11 |
PARP4, ADPRTL1, VPARP, KIAA0177 |
Poly(ADP-ribose) polymerase 4 |
607519 |
|
|
REc |
|
| 13q11 |
TUBA2 |
Tubulin, alpha 2 |
602528 |
|
|
REc |
|
| 13q11-q12 |
FGF9, SYNS3 |
Fibroblast growth factor-9 (glia-activating factor) |
600921 |
Multiple synostoses syndrome 3, 612961 (3) |
|
A |
|
| 13q11-q12 |
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID |
Gap junction protein, beta-2, 26kD (connexin 26) |
121011 |
Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomaldominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafnesssyndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3) |
|
REa, A, Fd |
14(Gjb2) |
| 13q11-q12 |
LATS2 |
Large tumor suppressor, Drosophila, homolog of, 2 |
604861 |
|
|
A |
14(Lats2) |
| 13q11-q12 |
PABPC3, PABP3, PABPL3 |
Polyadenylate-binding protein, cytoplasmic, 3 |
604680 |
|
|
Psh |
|
| 13q11-q12 |
ZNF198, SCLL, RAMP, FIM |
Zinc finger protein-198 |
602221 |
Stem-cell leukemia/lymphoma syndrome (3) |
|
REc, R, Ch |
|
| 13q12 |
ALOX5AP, FLAP |
Arachidonate 5-lipoxygenase-activating protein |
603700 |
{Stroke, susceptibility to}, 601367 (3) |
|
R, A, REc |
|
| 13q12 |
ATP8A2, ATPIB |
ATPase, class I, type 8A, member 2 |
605870 |
|
|
A |
|
| 13q12 |
CDK8 |
Cyclin-dependent kinase 8 |
603184 |
|
|
REc |
|
| 13q12 |
FLT1 |
fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor) |
165070 |
|
150kb from FLT3 |
REa, A |
|
| 13q12 |
FLT3 |
fms-related tyrosine kinase-3 |
136351 |
Leukemia, acute myeloid, reduced survival in (3); Leukemia,acute myeloid, 601626 (3); Leukemia, acute lymphoblastic (3) |
|
A, Psh, REn |
5(Flt3) |
| 13q12 |
GJB6, CX30, DFNA3B, HED, ED2, DFNB1B |
Gap junction protein, beta-6 (connexin-30) |
604418 |
Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3) |
|
Fd, H |
|
| 13q12 |
GPR12 |
G protein-coupled receptor-12 |
600752 |
|
|
A |
|
| 13q12 |
HMGB1, HMG1 |
High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1) |
163905 |
|
|
A |
5(Hmg1) |
| 13q12 |
KL, KLOTHO |
Klotho |
604824 |
{Coronary artery disease, susceptibility to} (3); Tumoral calcinosis,hyperphosphatemic, 211900 (3) |
|
A, REc |
|